BAZ2A
| Official symbol: | BAZ2A |
| Full name: | bromodomain adjacent to zinc finger domain 2A |
| Location: | 12q13.3 |
| Also known as: | KIAA0314, TIP5, WALp3 |
| Entrez ID: | 11176 |
| Ensembl ID: | ENSG00000076108 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Recurrently mutated in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 7 |
|
|
| Fusions detected in 6 cancer type(s) |
|
| |
|
|
|
| Functional class: | Epigenetic |
| JensenLab PubMed score: | 115.20 (Percentile rank: 74.74%) |
| PubTator score: | 26.69 (Percentile rank: 57.44%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
